{"id":"W2042177362","doi":"10.1155/2014/481071","title":"Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom","year":2014,"lang":"en","type":"article","venue":"Sarcoma","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); University of Toronto","funders":"GlaxoSmithKline","keywords":"Pazopanib; Medicine; Placebo; Oncology; Internal medicine; Adverse effect; Soft tissue sarcoma; Cost effectiveness; Clinical trial; Sarcoma; Sunitinib; Renal cell carcinoma; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008955183,0.0002059966,0.0004997551,0.0003382376,0.00003634908,0.00001132371,0.0001954986,0.00008935952,0.00003696465],"category_scores_gemma":[0.0002970767,0.0001405956,0.00008286196,0.0007952768,0.00008755752,0.00005660586,0.00004729358,0.0002174093,0.00002515193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001219725,"about_ca_system_score_gemma":0.00003968383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033639,"about_ca_topic_score_gemma":0.0003172982,"domain_scores_codex":[0.9981336,0.0005783435,0.0003564323,0.0002973781,0.0002998361,0.0003343822],"domain_scores_gemma":[0.997786,0.001469246,0.00009220097,0.0005224583,0.0000647701,0.00006527341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005931264,0.001908742,0.9096573,0.0001897879,0.00003980485,0.0002227889,0.0004711318,0.00008536214,0.004662942,0.00444991,0.00004481781,0.07767428],"study_design_scores_gemma":[0.006888795,0.0005380606,0.9685348,0.0005648619,0.00004794124,0.00005123807,0.0001741266,0.0002738112,0.01294066,0.0008532931,0.008994667,0.0001377003],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963328,0.0004802575,0.0001379282,0.0006343554,0.00008027033,0.001400559,0.000007127476,0.00002792008,0.0008988436],"genre_scores_gemma":[0.9987937,0.00002664175,0.0003147416,0.0004030442,0.00003641377,0.0003283598,0.00006200395,0.00002615077,0.000009008598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07753658,"threshold_uncertainty_score":0.5733321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05323139757187086,"score_gpt":0.3447351493824258,"score_spread":0.2915037518105549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}